Jane Chung
Chief Executive Officer at Sutro Biopharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Sutro Biopharma Inc., 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Sutro Biopharma Inc. June 5, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Sutro Biopharma Inc. | Option exercise | +788 | — | — |
| Mar 4, 2026 | Sutro Biopharma Inc. | Shares withheld for tax | −282 | $21.31 | $6,009 |
| Mar 2, 2026 | Sutro Biopharma Inc. | Option exercise | +7,750 | — | — |
| Mar 2, 2026 | Sutro Biopharma Inc. | Shares withheld for tax | −2,779 | $20.55 | $57,108 |
| Mar 1, 2026 | Sutro Biopharma Inc. | Option exercise | +688 | — | — |
| Mar 1, 2026 | Sutro Biopharma Inc. | Option exercise | +2,500 | — | — |
| Mar 1, 2026 | Sutro Biopharma Inc. | Shares withheld for tax | −1,271 | $20.47 | $26,017 |
| Dec 12, 2025 | Sutro Biopharma Inc. | Option exercise | +2,500 | — | — |
| Dec 12, 2025 | Sutro Biopharma Inc. | Shares withheld for tax | −894 | $8.02 | $7,170 |
| Oct 15, 2025 | Sutro Biopharma Inc. | Open-market purchase | +12,500 | $0.80 | $10,000 |
| Aug 9, 2025 | Sutro Biopharma Inc. | Option exercise | +18,750 | — | — |
| Aug 9, 2025 | Sutro Biopharma Inc. | Shares withheld for tax | −6,708 | $0.80 | $5,366 |
Questions about Jane Chung
What boards is Jane Chung on?
Jane Chung sits on the board of Sutro Biopharma Inc.
What company is Jane Chung the CEO of?
Jane Chung is Chief Executive Officer of Sutro Biopharma Inc.
How long has Jane Chung served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.